Open AccessSurvival advantage associated with metformin usage in hepatocellular carcinoma patients with diabetes mellitus receiving radical resection: a propensity score matching analysis
Author(s) -
Chen Luo,
YuHsuan Lin,
Weiping Zhou,
Jun Shi
Publication year - 2019
Publication title -
european journal of gastroenterology and hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.881
H-Index - 102
eISSN - 1473-5687
pISSN - 0954-691X
DOI - 10.1097/meg.0000000000001610
Subject(s) - medicine , metformin , propensity score matching , hazard ratio , diabetes mellitus , hepatocellular carcinoma , proportional hazards model , prospective cohort study , cohort study , surgery , confidence interval , gastroenterology , insulin , endocrinology
Metformin is associated with improved survival among hepatocellular carcinoma (HCC) patients with diabetes mellitus. However, the role of metformin in the survival of hepatitis B virus (HBV)-related HCC patients with diabetes mellitus after radical resection is unclear, so this study aimed to assess the effects of metformin on the clinical outcomes of patients who received radical resection for HCC.